Volume 28, Issue 128 (May & June 2020)                   J Adv Med Biomed Res 2020, 28(128): 171-174 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nokhostin F, Dargahi MalAmir M, Tutunchi S, Rezaeeyan H. Evaluation of Prognostic/Diagnostic Value of Hematological Markers in the Detection of Inflammation in Coronavirus Disease: A Review Study. J Adv Med Biomed Res. 2020; 28 (128) :171-174
URL: http://zums.ac.ir/journal/article-1-5965-en.html
1- Dept. of Internal Medicine, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Dept. of Pulmonology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3- Dept. of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4- High Institute for Education and Research in Transfusion Medicine, Tehran, Iran , hadi.rezaeeyan@yahoo.com
Abstract:   (19073 Views)

The Coronavirus infectious disease 2019 (COVID-19) has recently emerged as a pandemic and has endangered the lives of thousands of people worldwide. No specific treatment has been identified so far. However, the identification of diagnostic and prognostic factors in patients can be valuable for the application of preventive strategies. Increased platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), prothrombin time (PT), and D-dimer indices have been found in patients with increased inflammation and thrombosis and can lead to heart disease. Also, an increase in these indices is accompanied by worsening of the disease and impairment of the respiratory tract, which necessitates ventilation for the patients eventually. The evaluation of NLR, PLR, and coagulation parameters can be useful for identifying high-risk individuals who need to be intubated. Patient survival will improve by the timely identification and the use of appropriate treatment strategies.

Full-Text [PDF 216 kb]   (26003 Downloads) |   |   Full-Text (HTML)  (842 Views)  

The Coronavirus infectious disease 2019 (COVID-19) has recently emerged as a pandemic and has endangered the lives of thousands of people worldwide. No specific treatment has been identified so far. However, the identification of diagnostic and prognostic factors in patients can be valuable for the application of preventive strategies.


Type of Study: Review | Subject: Clinical medicine
Received: 2020/01/5 | Accepted: 2020/04/15 | Published: 2020/05/1

References
1. Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020: ;55(5):105938. [DOI:10.1016/j.ijantimicag.2020.105938]
2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Eng J Med. 2020; 382(8):727-33 [DOI:10.1056/NEJMoa2001017]
3. Guan W j, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020. 382:1708-1720
4. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in immunopathology; 2017: Springer. [DOI:10.1007/s00281-017-0629-x]
5. Kashanian M, Eshraghi N, Sheikhansari N, Bordbar A, Khatami E. Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. J Obst Gynaecol. 2018;38(6):770-6. [DOI:10.1080/01443615.2017.1413080]
6. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5(5):428-430. [DOI:10.1016/S2468-1253(20)30057-1]
7. Hui H, Zhang Y, Yang X, et al. Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. medRxiv. 2020. [DOI:10.1101/2020.02.24.20027052]
8. Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424-32. [DOI:10.1002/jmv.25685]
9. Navani RV, Baradi A, Huang KLC, et al. Preoperative platelet-to-lymphocyte ratio is not associated with postoperative atrial fibrillation. Ann Thoracic Surg. 2020. S0003-4975(20)30358-1 [DOI:10.1016/j.athoracsur.2020.02.008]
10. Qu R, Ling Y, Zhang Yh, et al. Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease‐19. J Med Virol. 2020. 10.1002/jmv.25767. [DOI:10.1002/jmv.25767]
11. Lefrançais E, Looney MR. Platelet biogenesis in the lung circulation. Physiol. 2019;34(6):392-401. [DOI:10.1152/physiol.00017.2019]
12. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020; 27(2):taaa021. [DOI:10.1093/jtm/taaa021]
13. Li XT, Fang H, Li D, et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction. Chinese Med J. 2020;133(4):415. [DOI:10.1097/CM9.0000000000000650]
14. Cao W, Yao X, Cen D, Zhi Y, Zhu N, Xu L. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):16. [DOI:10.1186/s12876-020-1167-x]
15. Rungelrath V, Kobayashi SD, DeLeo FR. Neutrophils in innate immunity and systems biology‐level approaches. Wiley Interdiscip Rev Sys Biol Med. 2020;12(1):e1458. [DOI:10.1002/wsbm.1458]
16. Hong H, Fang X, Huang H, Wang Z, Lin T, Yao H. The derived neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T‐cell lymphoma. Br J Haematol. 2020;189(5):908-912. [DOI:10.1111/bjh.16447]
17. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;ciaa248. [DOI:10.2139/ssrn.3541136]
18. Cataudella E, Giraffa CM, Di Marca S, et al. Neutrophil-to-lymphocyte ratio: an emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia. J Am Geriatrics Soc. 2017;65(8):1796-801. [DOI:10.1111/jgs.14894]
19. Francis A, Baynosa R. Ischaemia-reperfusion injury and hyperbaric oxygen pathways: a review of cellular mechanisms. Diving Hyperb Med. 2017;47(2):110-7.
20. Haybar H, Shahrabi S, Rezaeeyan H, Shirzad R, Saki N. Endothelial cells: from dysfunction mechanism to pharmacological effect in cardiovascular disease. Cardiovasc Toxicol. 2019;19(1):13-22. [DOI:10.1007/s12012-018-9493-8]
21. Li H, Zhao D, Diao M, et al. Hyperbaric oxygen treatments attenuate the neutrophil-to-lymphocyte ratio in patients with idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2015;153(4):606-12. [DOI:10.1177/0194599815589072]
22. Linkins LA, Takach Lapner S. Review of D-dimer testing: Good, Bad, and Ugly. Int J Lab Hematol. 2017;39 Suppl 1:98-103. [DOI:10.1111/ijlh.12665]
23. Javaherforooshzadeh F, Monajemzadeh SA, Soltanzadeh M, Janatmakan F, Salari A, Saeed H. A comparative study of the amount of bleeding and hemodynamic changes between dexmedetomidine infusion and remifentanil infusion for controlled hypotensive anesthesia in lumbar discopathy surgery: A double-blind, randomized, clinical trial. Anesth Pain Med. 2018;8(2): e66959. [DOI:10.5812/aapm.66959]
24. Yang C, Zhang C, Yuan J, Cui J, Qiao S. Prevalence and determinants of elevated D-dimer in patients with hypertrophic cardiomyopathy. Biomarker Med. 2020;14(2):131-40. [DOI:10.2217/bmm-2019-0225]
25. Vail GM, Xie YJ, Haney DJ, Barnes CJ. Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae. Infection. 2009;37(4):358-64. [DOI:10.1007/s15010-008-8128-6]
26. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-69. [DOI:10.1001/jama.2020.1585]
27. Huang D, Gao W, Wu R, Zhong X, Qian J, Ge J. D-dimer level predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction. Int J Cardiol. 2020;305:1-4. [DOI:10.1016/j.ijcard.2020.02.010]
28. Frydman GH, Ellett F, Van Cott EM, et al. A new test for the detection of direct oral anticoagulants (Rivaroxaban and Apixaban) in the emergency room setting. Crit Care Explor. 2019;1(8):e0024. [DOI:10.1097/CCE.0000000000000024]
29. Fan SL, Miller NS, Lee J, Remick DG. Diagnosing sepsis - the role of laboratory medicine. Clin Chim Acta. 2016; 460: 203-210. [DOI:10.1016/j.cca.2016.07.002]
30. Javaherforooshzadeh F, Amirpour I, Janatmakan F, Soltanzadeh M. Comparison of effects of melatonin and gabapentin on post operative anxiety and pain in lumbar spine surgery: A randomized clinical trial. Anesth Pain Med. 2018;8(3): e68763. [DOI:10.5812/aapm.68763]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 All Rights Reserved | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb  Co-Publisher: Farname Inc.